|
BUB1B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.88659999844631E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.168610E-04 |
| Normal-vs-Stage2 |
5.055600E-03 |
| Normal-vs-Stage3 |
2.48659999999568E-05 |
| Normal-vs-Stage4 |
4.73970000025581E-07 |
| Stage1-vs-Stage2 |
3.156600E-01 |
| Stage1-vs-Stage3 |
3.969600E-02 |
| Stage1-vs-Stage4 |
3.613300E-04 |
| Stage2-vs-Stage3 |
6.539000E-01 |
| Stage2-vs-Stage4 |
2.807900E-02 |
| Stage3-vs-Stage4 |
4.173800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.54820000153322E-08 |
| Normal-vs-AfricanAmerican |
3.206500E-02 |
| Normal-vs-Asian |
1.987800E-01 |
| Caucasian-vs-AfricanAmerican |
2.172200E-01 |
| Caucasian-vs-Asian |
4.865800E-01 |
| AfricanAmerican-vs-Asian |
3.658000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.89279999451841E-08 |
| Normal-vs-Female |
2.22380000000078E-05 |
| Male-vs-Female |
1.363620E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.456000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.1872999999829E-06 |
| Normal-vs-Age(61-80Yrs) |
2.71670000051571E-07 |
| Normal-vs-Age(81-100Yrs) |
7.988000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.741200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.593600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.276500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.962400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.838600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.337700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.124000E-02 |
| Normal-vs-Grade 2 |
1.187120E-04 |
| Normal-vs-Grade 3 |
1.51429999994956E-06 |
| Normal-vs-Grade 4 |
2.1360999999942E-06 |
| Grade 1-vs-Grade 2 |
3.375700E-02 |
| Grade 1-vs-Grade 3 |
1.842210E-03 |
| Grade 1-vs-Grade 4 |
7.67000000000406E-05 |
| Grade 2-vs-Grade 3 |
9.728400E-02 |
| Grade 2-vs-Grade 4 |
8.972500E-04 |
| Grade 3-vs-Grade 4 |
7.759700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.198200E-03 |
| Normal-vs-ccB subtype |
4.24780000063407E-08 |
| ccA subtype-vs-ccB subtype |
3.665900000005E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.85609999995229E-07 |
| Normal-vs-N1 |
1.408500E-04 |
| N0-vs-N1 |
5.955000E-04 |
|
|
